• Latest Posts
Opinion 30 Jun 2023

Virus tracking could be key to kidney transplant patients’ drug choices

Novartis acquires Chinook Therapeutics for $3.2B

FDA fast track for Memo’s kidney transplant infection treatment

New research may lead to gene therapies for kidney disease

Cambrian Bio to boost aging pipeline with Amplifier Therapeutics launch

ADVERTISEMENT

Calliditas shares rise as phase 3 endpoints met in kidney disease trial

5 advancements in kidney disease research over the past year

Orbsen Therapeutics happy with interim diabetic kidney disease study results 

New therapy transitions toxic immune cells from harmful to healing to fight effects of hyperinflammation in children

Early diagnosis tool for childhood kidney disease

EMPA-KIDNEY trial meets primary endpoint in trial for drug to treat chronic kidney disease

ADVERTISEMENT